top of page
Neurogenic
Develops sensitive immunoassays to facilitate the diagnosis of mental disorders.
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
Neurogenic | 02/09/2022 | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) | 01/01/1995 | "1-10" |
Neurogenic is a clinical-stage diagnostics company that develops sensitive immunoassays to facilitate the diagnosis of mental disorders. The company has developed a straightforward, highly sensitive, and specific blood test for the diagnosis of schizophrenia in children with behavioral disorders.
bottom of page